Growth Metrics

Catalyst Pharmaceuticals (CPRX) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.58%
Dec 31, 2025 -0.16%
Sep 30, 2025 -25.37%
Jun 30, 2025 29.86%
Mar 31, 2025 13.13%
Dec 31, 2024 16.89%
Sep 30, 2024 0.36%
Jun 30, 2024 -46.56%
Mar 31, 2024 94.07%
Dec 31, 2023 11.55%
Sep 30, 2023 15.52%
Jun 30, 2023 14.04%
Mar 31, 2023 50.16%
Dec 31, 2022 -6.28%
Sep 30, 2022 1.58%
Jun 30, 2022 6.31%
Mar 31, 2022 29.28%
Dec 31, 2021 -2.65%
Sep 30, 2021 -0.40%
Jun 30, 2021 -3.37%
Mar 31, 2021 6.94%
Dec 31, 2020 -0.61%
Sep 30, 2020 -17.61%
Jun 30, 2020 18.10%
Mar 31, 2020 32.14%
Dec 31, 2019 40.69%
Sep 30, 2019 -11.67%
Jun 30, 2019 -0.90%
Mar 31, 2019 -9.34%
Dec 31, 2018 35.80%
Sep 30, 2018 -4.21%
Jun 30, 2018 -18.51%
Mar 31, 2018 100.07%
Dec 31, 2017 -8.35%
Sep 30, 2017 -17.04%
Jun 30, 2017 -15.33%
Mar 31, 2017 54.33%
Dec 31, 2016 -8.18%
Sep 30, 2016 48.96%
Jun 30, 2016 -21.99%
Mar 31, 2016 -20.54%
Dec 31, 2015 74.24%
Sep 30, 2015 -9.10%
Jun 30, 2015 15.72%
Mar 31, 2015 9.32%
Dec 31, 2014 -35.31%
Sep 30, 2014 1,869.99%
Jun 30, 2014 -2.42%
Mar 31, 2014 -45.64%
Dec 31, 2013 -8.82%
Sep 30, 2013 3.96%
Jun 30, 2013 7.51%
Mar 31, 2013 -79.56%
Dec 31, 2012 348.12%
Sep 30, 2012 1.10%
Jun 30, 2012 0.00%
Mar 31, 2012 -81.89%
Dec 31, 2011 408.16%
Sep 30, 2011 -24.73%
Jun 30, 2011 21.07%
Mar 31, 2011 -78.15%
Dec 31, 2010 583.82%